Thakur Ankur, Alam Mohammad Tauqeer, Sharma Yagya D
Department of Biotechnology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India.
Acta Trop. 2008 Oct;108(1):58-63. doi: 10.1016/j.actatropica.2008.08.011. Epub 2008 Sep 6.
Plasmodium vivax merozoite surface protein 1 (PvMSP-1) is a leading malaria vaccine candidate. This protein is processed to give rise to various sized fragments during merozoite maturation. Here, we describe the analysis of genetic diversity in the 42 kDa C-terminal part of this protein among 33 Indian P. vivax isolates. A total of 27 haplotypes with 72 mutations and 0.0212+/-0.0005S.D. over all pi nucleotide diversity were observed among the isolates. Twenty-six of 27 haplotypes reported here were new as they have not been reported so far from any other country. The difference between non-synonymous (dN) and synonymous (dS) mutations was found to be positive (0.0081+/-0.0051) for the entire 42 kDa region. Further analysis revealed that 33 kDa (MSP-1(33)) fragment of the MSP-1(42) was highly polymorphic with pi nucleotide diversity 0.0290+/-0.0007S.D. The dN-dS for this region of MSP-1 was also positive (0.0114+/-0.0071S.E.). On the other hand, there was no non-synonymous mutation in the 19 kDa (MSP-1(19)) fragment of the MSP-1(42) and thus it was highly conserved. In conclusion, MSP-1(33) fragment was highly polymorphic and appeared to be under diversifying selection whereas there was no selection at MSP-1(19) region among the isolates. Present study will be helpful for the development of PvMSP-1 based vaccine against P. vivax malaria.
间日疟原虫裂殖子表面蛋白1(PvMSP-1)是一种主要的疟疾疫苗候选物。在裂殖子成熟过程中,该蛋白会被加工产生各种大小的片段。在此,我们描述了对33株印度间日疟原虫分离株中该蛋白42 kDa C末端部分的遗传多样性分析。在分离株中观察到总共27种单倍型,有72个突变,所有π核苷酸多样性的标准差为0.0212±0.0005。这里报告的27种单倍型中有26种是新的,因为迄今为止尚未在任何其他国家报告过。发现整个42 kDa区域的非同义(dN)突变和同义(dS)突变之间的差异为正值(0.0081±0.0051)。进一步分析表明,MSP-1(42)的33 kDa(MSP-1(33))片段高度多态,π核苷酸多样性为0.0290±0.0007标准差。MSP-1该区域的dN-dS也为正值(0.0114±0.0071标准误)。另一方面,MSP-1(42)的19 kDa(MSP-1(19))片段没有非同义突变,因此高度保守。总之,MSP-1(33)片段高度多态,似乎处于多样化选择之下,而分离株中MSP-1(19)区域没有选择作用。本研究将有助于开发基于PvMSP-1的间日疟疫苗。